This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_ORAL_EXALLC for full statistics.
Carcinoma in situ of oral cavity, oesophagus and stomach
CD2_INSITU_ORAL
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
131 |
4. Check minimum number of eventsNone |
131 |
5. Include endpoints |
187 |
6. Filter based on genotype QC (FinnGen only) |
187 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D00-D09
- Name in latin
- Carcinoma in situ cavitatis oris, oesophagi sive ventriculi
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of oral cavity, oesophagus and stomach
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of oral cavity, oesophagus and stomach
- In situ neoplasms
- In situ neoplasms
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 187 | 57 | 130 |
| Unadjusted period prevalence (%) | 0.05 | 0.02 | 0.06 |
| Median age at first event (years) | 69.05 | 70.30 | 68.50 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 169
- Matched controls
- 1690
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D00.2
ICD-10 Finland
Carcinoma in situ: Stomach
+∞
23.5
22
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
5.5
23.3
95
320
D00.1
ICD-10 Finland
Carcinoma in situ: Oesophagus
+∞
22.4
21
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
112.7
19.0
20
*
D00.00
ICD-10 Finland
Cancer in situ on the lip red border
+∞
18.0
17
*
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
20.2
17.6
26
15
130
Kela drug reimbursment
Malignant tumour
6.0
15.2
45
96
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
+∞
14.8
14
*
JCA45
NOMESCO Finland
Endoscopic mucosal or submucosal resection in oesophagus
163.5
14.7
15
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
21.6
14.7
21
11
K22.7
ICD-10 Finland
Barrett oesophagus
21.6
14.7
21
11
D00.06
ICD-10 Finland
Cancer in situ in another part of the tongue
+∞
13.7
13
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
151.6
13.7
14
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
43.9
13.4
16
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
18.7
13.4
20
12
D00.09
ICD-10 Finland
Unspecified cancer in situ in oral cavity and throat
+∞
12.7
12
*
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
139.9
12.6
13
*
EKA10
NOMESCO Finland
Biopsy of cheek
23.4
12.3
17
8
8140/3-C16.0
ICD-O-3
Adenocarcinoma, NOS, of cardia, NOS
+∞
11.6
11
*
D13.0
ICD-10 Finland
Benign neoplasm: Oesophagus
128.3
11.6
12
*
JCA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in oesophagus
128.3
11.6
12
*
WX002
NOMESCO Finland
Sedation and analgesia
3.8
11.0
53
182
WX402
NOMESCO Finland
General anaesthesia
4.5
10.8
41
113
C15.3
ICD-10 Finland
Malignant neoplasm: Upper third of oesophagus
+∞
10.5
10
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
34.9
10.5
13
*
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
34.9
10.5
13
*
EJB30
NOMESCO Finland
Excision of lesion of floor of mouth
105.6
9.5
10
*
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
105.6
9.5
10
*
D00.04
ICD-10 Finland
In situ cancer of the floor of the mouth
+∞
9.5
9
*
C159, 8148, 2
ICD-O-3
NA
+∞
9.5
9
*
UJD02
NOMESCO Finland
Gastroscopy
5.5
9.2
27
56
A03FA01
ATC
metoclopramide; systemic, rectal
3.4
9.1
50
187
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
29.2
8.6
11
*
ECA20
NOMESCO Finland
Biopsy of gingiva
29.2
8.6
11
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
9.3
8.5
17
20
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
35.2
8.2
10
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
35.2
8.2
10
*
TEA00
NOMESCO Finland
Biopsy of lip
23.4
8.1
11
5
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.8
8.1
67
325
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
16.0
7.8
12
8
UJC12
NOMESCO Finland
Flexible oesophagoscopy
19.5
7.7
11
6
N02AA05
ATC
oxycodone; systemic
3.1
7.6
46
182
107
Kela drug reimbursment
Pernicious anaemia
8.3
7.6
16
21
C15.4
ICD-10 Finland
Malignant neoplasm: Middle third of oesophagus
83.6
7.5
8
*
C16.09
ICD-10 Finland
Malignant tumor of cardiac or other unspecified carcinoma
83.6
7.5
8
*
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
+∞
7.3
7
*
D00.01
ICD-10 Finland
In situ cancer of the mucous membrane of the cheek
+∞
7.3
7
*
EAA10
NOMESCO Finland
Excision of lesion of lip
21.1
7.2
10
5
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
21.1
7.2
10
5
K13.78
ICD-10 Finland
Other change in the oral mucosa
10.7
7.2
13
13
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.0
7.2
19
35
SBA00
NOMESCO Finland
Microbiological examinations
9.9
6.9
13
14
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.8
6.9
29
87
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
41.8
6.8
8
*
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
23.6
6.7
9
*
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
4.5
6.7
23
57
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.0
6.5
20
44
8140/3-C16.9
ICD-O-3
Adenocarcinoma, NOS, of stomach, NOS
72.4
6.5
7
*
JCC12
NOMESCO Finland
Thoracoscopic or laparoscopic partial oesophagectomy
72.4
6.5
7
*
R4190
NOMESCO Finland
Nutritional therapy
8.7
6.5
13
16
B03BA03
ATC
hydroxocobalamin; parenteral
4.1
6.3
24
66
JN4BD
NOMESCO Finland
Extensive body CT
3.4
6.3
30
100
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
27.8
6.3
8
*
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
+∞
6.3
6
*
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
+∞
6.3
6
*
D00.05
ICD-10 Finland
In situ cancer of the pharyngeal part of the tongue
+∞
6.3
6
*
EAA30
NOMESCO Finland
Partial excision of lower lip
+∞
6.3
6
*
EDB00
NOMESCO Finland
Partial excision of mandible
+∞
6.3
6
*
C160, 8148, 2
ICD-O-3
NA
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
48
139
4.30
15.39
2.8
2.4
g/l
0.2
0.2
0.48
48
123
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
77
326
3.32
13.88
3.6
2.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
55
188
3.73
13.87
3.4
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
90
440
3.02
12.37
3.9
2.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
110
619
2.89
11.38
5.9
4.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
93
529
2.51
8.72
3.7
2.2
—
—
—
0
0
(4035726)
38
139
3.18
8.32
1.4
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
46
188
2.92
8.31
6.8
5.7
mmol/l
0.3
1.3
1.15
35
152
(3021960) Folate [Moles/volume] in Serum or Plasma
73
383
2.49
8.00
1.6
1.6
nmol/l
17.2
21.4
2.43
64
317
(3032080) INR in Blood by Coagulation assay
102
637
2.32
7.39
9.5
10.3
inr
1.1
1.3
—
10
183
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
13
8.07
7.19
3.0
2.5
—
—
—
0
0
(3002256) Pathology report gross observation
43
183
2.75
7.14
1.6
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
24
74
3.57
6.83
9.1
6.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
14
7.49
6.76
3.4
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
98
626
2.19
6.44
2.4
2.0
pmol/l
96.9
91.7
0.38
59
318
(3000991) Gas panel - Venous blood
33
133
2.80
6.02
6.9
6.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
48
237
2.38
5.78
2.4
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
28
108
2.87
5.53
1.8
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
102
691
2.05
5.45
6.9
5.5
mmol/l
1.2
1.2
1.24
93
615
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
108
749
2.05
5.38
8.1
6.3
mmol/l
1.2
1.2
1.12
96
616
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
67
392
2.11
5.30
3.3
2.1
mg/l
3.0
3.2
0.44
59
334
(3006315) Basophils [#/volume] in Blood
100
683
2.00
5.11
7.1
5.8
e9/l
0.0
0.0
0.49
84
579
(42870588) Differential panel, method unspecified - Blood
76
472
2.03
5.08
7.1
5.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
101
695
1.99
5.03
7.2
5.9
e9/l
2.5
1.8
0.44
87
600
(3037522) Nuclear Ab [Titer] in Serum
33
146
2.53
5.00
1.2
1.3
titre
537.1
296.6
—
7
29
(3001604) Monocytes [#/volume] in Blood
99
681
1.96
4.89
7.1
5.8
e9/l
0.7
0.6
1.05
83
574
(3014111) Lactate [Moles/volume] in Serum or Plasma
31
138
2.49
4.63
6.9
5.4
mmol/l
1.7
1.5
0.21
31
129
(3013115) Eosinophils [#/volume] in Blood
100
701
1.92
4.57
7.3
6.0
e9/l
0.2
0.2
1.53
87
601
(3017732) Neutrophils [#/volume] in Blood
21
77
2.95
4.52
5.0
3.0
e9/l
6.6
3.5
1.13
14
51
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
32
147
2.42
4.47
2.3
2.8
ug/l
3.2
5.5
1.88
25
131
(3023368) Bacteria identified in Blood by Culture
74
473
1.93
4.43
6.5
4.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
90
614
1.90
4.43
6.7
6.0
%
0.7
0.6
0.26
84
568
(3018010) Neutrophils/100 leukocytes in Blood
92
633
1.89
4.40
7.3
5.9
%
58.7
59.0
0.06
86
587
(3002030) Lymphocytes/100 leukocytes in Blood
93
644
1.88
4.34
7.5
6.1
%
25.5
25.8
0.05
86
594
(3006504) Eosinophils/100 leukocytes in Blood
91
629
1.87
4.25
7.4
6.0
%
2.3
2.9
2.17
85
582
(3019069) Monocytes/100 leukocytes in Blood
91
632
1.86
4.16
8.2
6.3
%
8.5
8.8
0.42
85
589
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
39
207
2.12
3.86
4.1
3.9
u/l
222.9
244.6
0.81
39
193
(3004789) Transferrin [Mass/volume] in Serum or Plasma
43
237
2.06
3.86
2.7
2.3
g/l
2.3
2.3
0.35
38
212
(3001122) Ferritin [Mass/volume] in Serum or Plasma
79
537
1.82
3.78
3.5
2.7
ug/l
123.3
155.5
0.89
73
487
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
19
73
2.78
3.77
1.8
2.2
ug/l
3.1
0.8
1.02
13
66
(3013650) Neutrophils [#/volume] in Blood by Automated count
106
788
1.80
3.75
12.7
9.5
e9/l
4.7
4.3
0.55
96
677
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
21
86
2.62
3.70
8.6
7.1
mmol/l
23.8
24.8
0.94
21
79
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
9
8.02
3.59
2.3
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
32
162
2.18
3.56
2.1
2.5
e9/l
73.3
68.4
0.37
19
128
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
77
529
1.77
3.50
4.1
3.3
ng/l
1847.8
1790.7
0.05
66
440
(3015377) Calcium [Moles/volume] in Serum or Plasma
74
505
1.77
3.43
4.0
3.2
mmol/l
2.3
2.3
0.02
64
443
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34
180
2.09
3.38
10.4
9.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
48
3.07
3.38
1.7
1.8
u/ml
0.2
0.3
—
6
25
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
45
264
1.93
3.37
2.4
2.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
40
228
1.96
3.25
2.8
2.4
%
17.7
22.5
1.54
30
199
(1761868) Lipid panel - Serum or Plasma
23
441
0.45
3.22
3.3
3.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
25
120
2.25
3.16
1.9
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
33
178
2.04
3.12
2.1
1.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
16
5.17
3.08
1.4
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
46
283
1.83
2.96
5.1
3.4
ng/l
155.7
118.2
0.16
40
237
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
58
2.72
2.95
6.0
3.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
13
47
2.90
2.88
1.2
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
42
257
1.82
2.74
2.7
2.9
e6/l
0.5
1.1
1.99
28
158
(4024509)
6
10
6.16
2.72
2.0
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
32
181
1.93
2.65
2.0
1.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
124
1017
1.65
2.64
5.3
4.1
mm/h
17.4
13.7
1.32
119
918
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
75
555
1.59
2.38
2.6
2.3
nmol/l
79.4
76.2
0.46
64
475
(46235355) HIV 1 and 2 tests - Meaningful Use set
27
150
1.94
2.35
1.4
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
36
2.88
2.24
2.0
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
23
123
1.99
2.23
1.6
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
9
5.67
2.22
1.0
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
19
95
2.11
2.19
2.3
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
30
177
1.83
2.19
1.8
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
82
631
1.53
2.14
5.1
4.5
ng/l
39.5
52.0
0.45
66
490
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
74
558
1.54
2.12
3.6
3.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
20
3.59
2.07
1.7
1.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
22
120
1.94
2.03
5.8
3.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
9
32
2.90
2.03
2.3
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
49
339
1.60
2.02
9.2
6.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
21
3.42
1.98
1.7
1.7
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
7
21
3.42
1.98
8.6
2.4
nmol/l
4.0
3.4
—
7
21
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
21
3.42
1.98
1.7
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
21
3.42
1.98
1.7
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
21
3.42
1.98
1.7
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
45
307
1.61
1.96
1.6
1.7
mg/l
1.4
1.5
0.13
37
236
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
113
943
1.50
1.95
3.3
3.7
pmol/l
14.8
15.0
0.31
103
821
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
22
3.26
1.90
1.7
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
47
327
1.58
1.89
1.7
1.8
nmol/l
1164.8
1255.6
0.27
34
244
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
28
2.94
1.88
1.4
1.5
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
5
12
4.25
1.83
1.2
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
25
149
1.78
1.78
1.6
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
38
255
1.62
1.77
1.7
1.9
s
29.4
29.7
0.14
38
245
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
24
2.99
1.74
1.4
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
60
449
1.50
1.73
3.8
4.2
mg/mmol
5.9
12.9
1.48
44
295
(3012516) Albumin [Mass/volume] in Urine
57
422
1.50
1.73
3.5
3.3
mg/l
993.0
220.2
0.37
40
286
(3021879) Hepatitis B virus core Ab [Presence] in Serum
17
90
1.98
1.71
1.5
1.4
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
11
49
2.32
1.67
1.0
1.1
—
—
—
0
0
(3019225) pH of Specimen
23
137
1.77
1.64
6.5
4.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
55
410
1.48
1.60
3.7
3.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
20
115
1.83
1.60
3.8
3.6
ml/min/173m2
69.1
59.9
—
8
49
(3021788) Differential panel - Synovial fluid
6
20
3.06
1.59
2.8
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
22
131
1.77
1.58
1.6
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
16
87
1.92
1.51
5.8
3.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
37
2.50
1.50
1.7
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
38
2.44
1.48
1.3
2.6
—
—
—
0
0
(3012544) pH of Venous blood
24
150
1.69
1.47
3.8
3.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
57
435
1.45
1.46
3.4
3.2
mmol/l
7.1
7.5
0.25
49
354
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
28
2.56
1.46
1.0
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
28
2.56
1.46
1.6
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
22
2.78
1.44
2.5
4.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
57
437
1.44
1.43
3.8
3.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
10
46
2.24
1.42
1.8
1.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
35
244
1.53
1.39
3.0
3.2
e6/l
1.1
1.8
0.58
21
146
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
41
2.25
1.39
1.8
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
41
2.25
1.39
1.8
1.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
148
1347
1.47
1.34
32.8
17.0
mg/l
33.6
25.6
1.72
135
1114
(40761535) Cells panel - Urine sediment
21
130
1.69
1.33
3.1
4.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
43
317
1.46
1.31
1.2
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
28
188
1.58
1.31
4.6
4.7
%
30.6
31.3
0.11
16
121
(3007853) Bacteria identified in Skin by Aerobe culture
25
164
1.61
1.28
2.7
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
70
1.92
1.27
2.8
5.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
9
171
0.50
1.25
3.0
3.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
56
438
1.40
1.24
3.7
3.3
e6/l
0.3
0.4
0.55
44
329
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
82
684
1.35
1.22
2.9
2.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
26
2.35
1.19
1.2
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
26
2.35
1.19
1.0
2.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
50
2.06
1.19
1.5
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
72
1.87
1.18
1.0
2.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
72
1.87
1.18
1.0
2.2
g/l
4.2
3.8
—
7
51
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
72
1.87
1.18
1.0
2.2
g/l
8.0
7.5
—
7
54
(3011397) Hemoglobin [Presence] in Urine by Test strip
41
306
1.44
1.18
3.9
4.2
—
—
—
0
0
(3009343) pH of Capillary blood
19
119
1.66
1.17
5.8
3.4
—
7.4
—
0
11
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
65
1.90
1.16
3.2
2.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
30
2.38
1.13
1.4
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
30
2.38
1.13
1.4
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
14
81
1.79
1.12
2.1
2.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
132
1193
1.36
1.11
4.7
4.5
mu/l
2.1
2.0
0.31
120
1045
(42529406) Shigella sp [Presence] in Stool by Culture
8
41
1.99
1.10
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
41
1.99
1.10
1.3
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
32
2.23
1.09
1.3
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
27
372
0.68
1.05
3.6
3.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
48
1.92
1.02
1.3
1.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
7
35
2.04
1.01
3.3
1.7
umol/l
25.0
28.7
—
7
29
(4010399)
17
108
1.63
1.00
1.8
1.3
—
—
—
0
0
(3020891) Body temperature
12
69
1.79
0.99
5.8
3.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
23
2.20
0.98
1.2
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
27
2.26
0.94
1.3
1.7
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
6
27
2.26
0.94
1.0
2.0
—
22.9
—
0
7
(3018418) pH of Serum or Plasma
56
459
1.31
0.91
3.1
4.2
ph
7.4
7.4
—
5
92
(36660697) Celiac disease serology panel - Serum
13
79
1.69
0.90
1.8
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
58
478
1.31
0.90
3.8
3.6
e6/l
86.1
172.2
0.27
48
368
(3018095) Leukocytes [#/volume] in Urine
64
535
1.30
0.90
4.2
4.2
e6/l
73.0
75.0
0.02
48
393
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
42
1.94
0.90
1.3
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
8
42
1.94
0.90
3.8
4.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
56
1.83
0.89
1.3
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
72
1.71
0.87
2.8
2.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
57
1.80
0.85
1.2
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
31
1.97
0.85
1.5
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
126
1153
1.28
0.84
34.3
17.1
%
35.6
39.9
2.92
79
745
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
18
122
1.53
0.84
1.4
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
32
1.90
0.82
2.0
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
25
0.00
0.79
0.0
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
26
0.00
0.79
0.0
2.9
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
26
0.00
0.79
0.0
2.4
—
33.7
—
0
26
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
10
59
1.73
0.77
3.2
4.1
—
3.7
—
0
6
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
10
59
1.73
0.77
3.3
4.2
mg/l
23.4
31.9
—
10
46
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
24
2.11
0.75
5.0
3.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
24
2.11
0.75
2.0
2.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
60
1.70
0.73
2.9
1.9
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
9
57
1.61
0.72
1.3
1.2
u/ml
73.8
226.7
—
9
49
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
26
1.95
0.71
1.2
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
104
943
1.23
0.69
5.8
4.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
48
400
1.27
0.68
2.9
2.9
umol/l
19155.8
6212.4
0.47
42
337
(3004588) Protein electrophoresis panel - Serum or Plasma
17
120
1.46
0.67
3.1
2.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
44
1.61
0.66
3.6
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
31
383
0.77
0.62
4.4
4.5
estimate
0.0
0.0
—
6
134
(3034770) Mitochondria Ab [Titer] in Serum
5
30
1.68
0.62
1.4
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
52
1.56
0.60
1.1
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
12
81
1.51
0.58
1.4
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
97
0.61
0.53
1.8
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
22
171
1.32
0.53
1.3
1.3
u/ml
2.0
12.2
—
5
64
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
6
40
1.52
0.52
1.3
1.2
g/l
0.2
0.2
—
6
40
(3007164) IgA [Mass/volume] in Serum or Plasma
28
230
1.26
0.46
1.4
1.5
g/l
3.0
3.0
0.00
15
138
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
31
1.63
0.43
1.0
2.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
132
1255
1.18
0.42
7.6
6.4
mmol/mol
42.4
41.4
0.59
120
1150
(3000012) Reticulocyte production index
0
15
0.00
0.41
0.0
2.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
8
61
1.33
0.40
1.3
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
103
1095
0.87
0.40
39.8
20.5
%
14.3
14.0
1.54
103
1071
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
35
1.44
0.39
1.0
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
35
1.44
0.39
1.8
3.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
36
1.40
0.38
1.4
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
6
42
1.44
0.36
1.3
1.3
g/l
1.2
1.1
—
6
42
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
45
1.34
0.34
1.7
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
144
1389
1.16
0.33
27.6
16.0
—
—
—
0
0
(4034850)
7
52
1.36
0.31
9.0
12.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
48
528
0.88
0.29
4.3
4.5
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
146
1414
1.15
0.29
37.8
19.9
umol/l
85.4
84.9
0.07
146
1414
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
57
1.24
0.29
1.3
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
28
243
1.18
0.29
1.6
1.2
u/ml
0.7
0.8
—
8
66
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
131
1262
1.13
0.28
27.7
16.3
ml/min/173m2
72.7
74.6
0.46
118
1043
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
8
67
1.20
0.26
1.5
2.8
pmol/l
4.0
4.3
—
8
56
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
63
586
1.11
0.25
3.5
4.4
%
16.9
21.5
1.53
22
285
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
9
77
1.18
0.24
2.2
4.2
mmol/l
24.2
24.2
—
9
71
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
10
78
1.30
0.24
1.5
1.2
—
52.5
—
0
6
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
82
0.72
0.24
1.3
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
38
1.32
0.23
1.4
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016750) Collection duration of Urine
0
10
0.00
0.21
0.0
2.1
—
501.0
—
0
5
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
12
0.00
0.21
0.0
2.3
—
473.3
—
0
6
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
43
1.17
0.21
1.2
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
49
1.23
0.20
1.8
3.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
16
138
1.17
0.18
1.3
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
10
82
1.23
0.17
2.1
4.0
e6/l
0.2
0.2
—
10
82
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
22
196
1.14
0.17
1.3
1.2
iu/ml
30.9
38.3
—
8
67
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
37
346
1.09
0.13
1.5
1.8
pmol/l
566.2
427.1
0.43
27
280
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
76
732
1.06
0.13
5.5
5.0
ug/l
1.7
2.7
1.16
70
647
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
135
1324
1.07
0.12
5.3
5.3
mmol/l
2.3
2.6
2.67
126
1179
(3044889) 12 lead EKG panel
100
973
1.06
0.12
5.2
4.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
128
1303
0.94
0.10
5.6
5.0
mmol/l
6.3
6.1
0.78
119
1157
(3021589) Normoblasts [#/volume] in Blood
65
627
1.06
0.10
11.4
11.3
e9/l
0.0
0.0
0.59
49
505
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
127
1252
1.04
0.07
4.3
4.2
mmol/l
1.4
1.3
0.75
116
1105
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
131
1293
1.04
0.06
4.8
4.7
mmol/l
4.2
4.4
1.40
121
1164
(40760892) CBC W Ordered Manual Differential panel - Blood
27
283
0.95
0.05
6.7
5.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
68
665
1.04
0.05
4.1
4.3
estimate
0.0
0.0
—
6
131
(3013512) EKG study
45
462
0.97
0.04
6.9
4.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
12
129
0.93
0.03
3.3
5.1
%
3.2
1.0
—
5
51
(3021601) Nitrite [Presence] in Urine by Test strip
65
660
0.98
0.02
5.6
5.7
estimate
0.0
0.0
—
6
140
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
129
1284
1.02
0.00
4.8
4.6
mmol/l
1.4
1.4
0.21
119
1143
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
43
429
1.00
0.00
1.8
3.0
ug/l
0.7
0.8
0.36
25
285
(3035350) Ketones [Presence] in Urine by Test strip
66
661
1.00
0.00
4.0
4.3
estimate
0.0
0.0
—
6
143
(3000492) Spirometry study
12
117
1.03
0.00
1.2
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
8
0.00
0.00
0.0
2.1
—
4.6
—
0
8
(3025577) Chromium [Mass/volume] in Blood
0
8
0.00
0.00
0.0
2.1
—
2.3
—
0
8
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
260.9
—
0
8
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
1.9
—
0
8
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
69
1.02
0.00
2.6
2.9
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
6.4
—
117.2
—
0
5
(3008536) Aspergillus sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4027681)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
110.0
—
0
5
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
1.2
—
1.3
—
0
6
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(44813793)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
18.9
—
0
6
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
7
0.00
0.00
0.0
2.4
—
2607.1
—
0
7
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
6
0.00
0.00
0.0
6.7
—
45.8
—
0
6
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
5
0.00
0.00
0.0
11.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.5
—
112.0
—
0
6
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
7
0.00
0.00
0.0
1.6
—
32.9
—
0
7
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.2
—
1.2
—
0
5
(44806420)
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(4015189)
0
6
0.00
0.00
0.0
4.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_ORAL – Carcinoma in situ of oral cavity, oesophagus and stomach
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).